JP2024522620A5 - - Google Patents

Info

Publication number
JP2024522620A5
JP2024522620A5 JP2023575802A JP2023575802A JP2024522620A5 JP 2024522620 A5 JP2024522620 A5 JP 2024522620A5 JP 2023575802 A JP2023575802 A JP 2023575802A JP 2023575802 A JP2023575802 A JP 2023575802A JP 2024522620 A5 JP2024522620 A5 JP 2024522620A5
Authority
JP
Japan
Prior art keywords
weeks
use according
subject
binding protein
pharmaceutical product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023575802A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024522620A (ja
Filing date
Publication date
Priority claimed from GBGB2108379.5A external-priority patent/GB202108379D0/en
Application filed filed Critical
Publication of JP2024522620A publication Critical patent/JP2024522620A/ja
Publication of JP2024522620A5 publication Critical patent/JP2024522620A5/ja
Pending legal-status Critical Current

Links

JP2023575802A 2021-06-11 2022-06-10 アトピー性皮膚炎及び関連する障害の治療方法 Pending JP2024522620A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB2108379.5A GB202108379D0 (en) 2021-06-11 2021-06-11 Methods for treating a topic dermatitis and related disorders
GB2108379.5 2021-06-11
PCT/EP2022/065851 WO2022258814A1 (en) 2021-06-11 2022-06-10 Methods for treating atopic dermatitis and related disorders

Publications (2)

Publication Number Publication Date
JP2024522620A JP2024522620A (ja) 2024-06-21
JP2024522620A5 true JP2024522620A5 (https=) 2025-06-17

Family

ID=76954592

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023575802A Pending JP2024522620A (ja) 2021-06-11 2022-06-10 アトピー性皮膚炎及び関連する障害の治療方法

Country Status (9)

Country Link
US (1) US20250059269A1 (https=)
EP (1) EP4351641A1 (https=)
JP (1) JP2024522620A (https=)
AU (1) AU2022289697A1 (https=)
CA (1) CA3221119A1 (https=)
GB (1) GB202108379D0 (https=)
IL (1) IL309053A (https=)
TW (1) TW202317184A (https=)
WO (1) WO2022258814A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2026508149A (ja) * 2023-02-13 2026-03-10 インターベット インターナショナル ベー． フェー． イヌｉｌ－１３に対するイヌ抗体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0407315D0 (en) 2003-07-15 2004-05-05 Cambridge Antibody Tech Human antibody molecules
AU2006296399B2 (en) 2005-09-30 2011-01-20 Medimmune Limited Interleukin-13 antibody composition
BR112019018022A2 (pt) 2017-03-01 2020-06-02 Medimmune Limited Formulações de anticorpos monoclonais

Similar Documents

Publication Publication Date Title
KR102757960B1 (ko) 간세포암(hepatocellular carcinoma: HCC)에 대한 면역 치료
JP2023515271A5 (https=)
US10913792B2 (en) Treatment for rheumatoid arthritis
US11591406B2 (en) Treatment for multiple myeloma (MM)
US20230303677A1 (en) Methods of treating new-onset plaque type psoriasis using il-17 antagonists
JP2022033868A5 (https=)
JP2023524149A5 (https=)
US8617548B2 (en) Methods of preventing or treating anthrax using anti-anthrax antibodies
JP2015517511A (ja) Ｃｄ３７抗体とｉｃｅ（イフォスファミド、カルボプラチン、エトポシド）の併用
JP2021512107A5 (https=)
JP2015517512A (ja) Ｃｄ３７抗体の更なる薬剤との併用
JP2019519584A5 (https=)
JP2015516980A (ja) Ｃｄ３７抗体とベンダムスチンとの併用
JP2024522620A5 (https=)
TWI834254B (zh) α-烯醇酶拮抗劑治療纖維化疾病之用途
JP2025509567A5 (https=)
JP2022513029A5 (https=)
JP2023531722A5 (https=)
JP2023534576A5 (https=)
TW202317184A (zh) 用於治療異位性皮膚炎和相關障礙之方法
JP2016527200A (ja) Ｃｄ３７抗体とクロラムブシルの併用
WO2018158741A1 (en) Psoriasis disease modification following long-term treatment with an il-17 antagonist
JP2025508832A5 (https=)
WO2026060205A1 (en) PAN-ELR+ CXC CHEMOKINE ANTIBODIES AND IL-23p19 ANTIBODIES FOR THE TREATMENT OF ULCERATIVE COLITIS
RU2025131684A (ru) Способы лечения множественной миеломы